Article Text

PDF
A systematic review of performance-enhancing pharmacologicals and biotechnologies in the Army
  1. Henry Ko1,
  2. KE Hunter1,
  3. AM Scott2,
  4. M Ayson1 and
  5. ML Willson1
  1. 1NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia
  2. 2Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Queensland, Australia
  1. Correspondence to Dr ML Willson, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW 2050, Australia; Melina.Willson{at}ctc.usyd.edu.au

Abstract

Introduction In 2015, the Australian Army commissioned a systematic review to assess the evidence on effectiveness and safety of pharmacological and biotechnological products for cognitive enhancement specifically in Army personnel.

Methods Searches for studies examining biotechnological and pharmacological products in Army populations were conducted in December 2015. Cochrane CENTRAL, MEDLINE, EMBASE, CINAHL and PsycINFO were searched without date or language restrictions. WHO’s International Clinical Trials Registry Platform and ClinicalTrials.gov were searched to identify ongoing trials. Studies meeting inclusion criteria were evaluated for risk of bias using Cochrane's Risk of Bias tool. Due to heterogeneity of findings, meta-analysis could not be conducted. Findings were synthesised narratively and by vote-counting method.

Results Sixteen pharmacological enhancement products were evaluated in 22 randomised controlled trials (RCTs), involving 1284 personnel. Only three of the studies were published since 2010. The interventions evaluated were varied, including supplements (eg, carbohydrate), stimulants (eg, caffeine) and hormones (eg, melatonin). Generally, caffeine provided an improvement in performance compared with placebo on 5/7 reported cognitive outcomes, followed by levothyroxine (four cognitive outcomes) and prazosin (three cognitive outcomes). Performance results were mixed (finding an improvement and no effect in comparison to placebo) for caffeine and melatonin on two outcomes. No evidence was found pertaining to biotechnological products. Studies rarely reported safety outcomes (eg, adverse events and addiction).

Conclusion Findings from this review need to be interpreted with considerable caution. Future studies should include outcomes such as acute and long-term adverse events, and should evaluate cognitive performance using cognitive tests that are specific to the Army population.

  • EPIDEMIOLOGY, Health &amp
  • safety &lt
  • HEALTH SERVICES ADMINISTRATION &amp
  • MANAGEMENT, STATISTICS &amp
  • RESEARCH METHODS

Statistics from Altmetric.com

Footnotes

  • Contributors All authors contributed to the conception, design, analysis and interpretation of the manuscript as well as its writing.

  • Funding This manuscript presents the findings of a systematic review commissioned by the Australian Army, contract number DAR005-15.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.